530207 — Brawn Biotech Balance Sheet
0.000.00%
- IN₹51.01m
- IN₹37.04m
- IN₹134.65m
Annual balance sheet for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 15.7 | 15.2 | 14 |
Net Total Accounts Receivable | |||
Net Total Receivables | 53.3 | 39 | 34.3 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 134 | 131 | 175 |
Net Property, Plant And Equipment | 3.72 | 3.33 | 4.6 |
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 145 | 146 | 205 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 80.5 | 65.1 | 93.3 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 82.2 | 95.2 | 171 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 63.1 | 50.7 | 33.6 |
Total Liabilities & Shareholders' Equity | 145 | 146 | 205 |
Total Common Shares Outstanding |